Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Members of the University have been recognised in the New Year's Honours list for 2018, including scientists from across the Medical Sciences Division.

© Credit: Greg Smolonski. This images comes from Oxford University Images

Image credit to Greg Smolonski. This image comes from Oxford University Images 

Congratulations to Professor Chas Bountra, Dr Ben Goldacre, and Dr Jake Dunning, who have been recognised in the New Year's Honours List for 2018. 

Chas Bountra, Professor of Translational Medicine at the Nuffield Department of Clinical Medicine, was appointed OBE for services to Translational Medical Research.

Dr Ben Goldacre, Senior Clinical Research Fellow at the Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, was appointed MBE for services to Evidence in Policy.

Dr Jake Dunning, Honorary Visiting Research Fellow in Tropical Medicine (Epidemic diseases Research Group Oxford) and Deputy Programme Director for High Consequence Infectious Diseases, NHS England, was appointed MBE for services to Clinical Research.

Find out more (University of Oxford website)

Similar stories

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.

One high altitude explorer acknowledges another

NASA Astronaut and Physiologist Dr Jessica Meir unveils The Physiological Society blue plaque in honour of fellow pioneering Physiologist and Scientific Explorer Mabel FitzGerald.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.